Advanced Enzyme Technologies Limited — Updates, 13-05-2025: Press Release

Advanced Enzymes has announced a board meeting to review the financial results for the quarter and half-year. Q4 revenue increased 6% YoY to ₹1672 Mn, led by a 20% rise in international sales, especially in the Americas (+22%) and Asia ex-India (+48%). Animal Nutrition and Specialized Manufacturing segments grew 13% and 39% respectively. EBITDA and PAT declined due to margin pressures. The company is expanding its B2C nutraceutical brand Wellfa in India, boosting probiotics, and investing in R&D and acquisitions to drive growth.